<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02698345</url>
  </required_header>
  <id_info>
    <org_study_id>1-2015-0081</org_study_id>
    <nct_id>NCT02698345</nct_id>
  </id_info>
  <brief_title>Korean Multicenter Prospective Registry of In.PACT DEB for Isolated Popliteal Artery Disease (K-POP Study)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Prospective, multi-center, single-arm registry study

        -  A total of 100 subjects with isolated popliteal artery lesions according to inclusion
           and exclusion criteria will be enrolled.

        -  All popliteal artery lesions will be treated with drug-eluting balloon (In.PACT Admiral,
           Medtronic). • Atherectomy or use of bare nitinol stent in combination with drug-eluting
           balloon is allowed • Patients will be followed clinically for 12 months after the
           procedure.

        -  Imaging study (Duplex ultrasound, CT angiography or catheter angiography) follow-up will
           be performed at 12 months.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary patency</measure>
    <time_frame>12 months after the index procedure</time_frame>
    <description>Primary patency: absence of restenosis &gt;50% based on an imaging study (Duplex ultrasound, CT angiography or catheter angiography) at 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularization rate</measure>
    <time_frame>12 months</time_frame>
    <description>frequency of repeat intervention or surgical treatment due to loss of patency at the target vessel</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Popliteal Artery Disease</condition>
  <arm_group>
    <arm_group_label>K-POP</arm_group_label>
    <description>Patients with isolated popliteal artery disease undergoing endovascular therapy using drug-eluting balloon (In.PACT Admiral, Medtronic)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>drug-eluting balloon (In.PACT Admiral, Medtronic)</intervention_name>
    <arm_group_label>K-POP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with isolated popliteal artery disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 19 years or older

          2. Symptomatic peripheral artery disease:

               -  Moderate or severe claudication (Rutherford category 2 or 3)

               -  Critical limb ischemia (Rutherford category 4 or 5)

          3. Atherosclerotic popliteal artery disease (stenosis &gt; 50%)

          4. Patients with signed informed consent

        Exclusion Criteria:

          1. Acute critical limb ischemia

          2. Severe critical limb ischemia (Rutherford category 6)

          3. Involvement of SFA disease with stenosis

          4. Continous total occlusion of all proximal infrapopliteal arteries (origin of the
             anterior tibial artery or tibioperoneal trunk).

          5. Known hypersensitivity or contraindication to any of the following medications:
             heparin, aspirin, clopidogrel, or contrast agent

          6. Age &gt; 85 years

          7. Severe hepatic dysfunction (&gt; 3 times normal reference values)

          8. Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding
             diathesis

          9. LVEF &lt; 40% or clinically overt congestive heart failure

         10. Pregnant women or women with potential childbearing

         11. Life expectancy &lt;1 year due to comorbidity

         12. Previous bypass surgery or stenting for the target popliteal artery

         13. Untreated inflow disease of the ipsilateral pelvic or femoropopliteal arteries (more
             than 50% stenosis or occlusion)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young-Guk Ko, MD</last_name>
      <phone>82-2-2228-8460</phone>
      <email>ygko@yuhs.ac</email>
    </contact>
    <contact_backup>
      <last_name>Hyuck-Moon Kwon, MD, Ph.D</last_name>
      <phone>82-2-2019-3310</phone>
      <email>kwonhm@yuhs.ac</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 29, 2016</study_first_submitted>
  <study_first_submitted_qc>February 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2016</study_first_posted>
  <last_update_submitted>February 29, 2016</last_update_submitted>
  <last_update_submitted_qc>February 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Popliteal artery disease, drug-eluting balloon, angioplasty</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

